Detalhe da pesquisa
1.
Expanding the Scope of Ugi Multicomponent Bioconjugation to Produce Pneumococcal Multivalent Glycoconjugates as Vaccine Candidates.
Bioconjug Chem
; 31(9): 2231-2240, 2020 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32809806
2.
Real-world effectiveness of the heterologous SOBERANA-02 and SOBERANA-Plus vaccine scheme in 2-11 years-old children during the SARS-CoV-2 Omicron wave in Cuba: a longitudinal case-population study.
Lancet Reg Health Am
; 34: 100750, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38699214
3.
Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children.
Int J Infect Dis
; 126: 164-173, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36403819
4.
Repeat-dose and local tolerance toxicity of SARS-CoV-2 FINLAY-FR-02 vaccine candidate in Sprague Dawley rats.
Toxicology
; 471: 153161, 2022 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35364223
5.
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults.
Med
; 3(11): 760-773.e5, 2022 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998623
6.
A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles.
RSC Chem Biol
; 3(2): 242-249, 2022 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35360883
7.
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials.
Vaccine
; 40(31): 4220-4230, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35691871
8.
Glycan Array Evaluation of Synthetic Epitopes between the Capsular Polysaccharides from Streptococcus pneumoniae 19F and 19A.
ACS Chem Biol
; 16(9): 1671-1679, 2021 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34469105
9.
Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines.
ACS Cent Sci
; 7(5): 757-767, 2021 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34075345
10.
SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies.
ACS Chem Biol
; 16(7): 1223-1233, 2021 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34219448
11.
Design and Biological Assembly of Polyester Beads Displaying Pneumococcal Antigens as Particulate Vaccine.
ACS Biomater Sci Eng
; 4(9): 3413-3424, 2018 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33435075
12.
From individual to herd protection with pneumococcal vaccines: the contribution of the Cuban pneumococcal conjugate vaccine implementation strategy.
Int J Infect Dis
; 60: 98-102, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28457742
13.
Prevalence of Pneumococcal Nasopharyngeal Carriage Among Children 2-18 Months of Age: Baseline Study Pre Introduction of Pneumococcal Vaccination in Cuba.
Pediatr Infect Dis J
; 36(1): e22-e28, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27649366
14.
La nueva vacuna cubana antineumocócica, de las evidencias científicas disponibles, a la estrategia de evaluación clínica y de impacto / New Cuban pneumococcal vaccine, from available scientific evidence to the strategy of clinical and impact evaluation
Rev. cuba. pediatr
; 89(supl.1): 181-196, 2017.
Artigo
em Espanhol
| LILACS, CUMED | ID: biblio-901459